[ORGANIZATION]
Protagonist Therapeutics, Inc.
Featured in 2 tracked stories · first seen
Situations
Agribusiness earnings outlooks 2026
2 clusters · 15 sources · last updated
Latest: Corporate Financial Disclosures: Stake Increases and Earnings Calls
In late July 2026 Bunge and Corteva reported strong results and raised guidance. Bunge posted Q2 adjusted earnings of $2.00 per share on $24.04 billion revenue, lifting its full‑year target to $9.25‑$9.75 per share. Cort
Also covered in
-
Protagonist Therapeutics and PPL report earnings updates
[BUSINESS] · 2 sources ·